Please login to the form below

Not currently logged in
Email:
Password:

Immodulon

This page shows the latest Immodulon news and features for those working in and with pharma, biotech and healthcare.

Latest appointments

  • Immodulon Therapeutics bolsters senior team Immodulon Therapeutics bolsters senior team

    Independent biopharmaceutical company Immodulon Therapeutics has appointed Dr Jerome Zeldis as its executive vice chairman. ... the continued clinical development and commercialisation of Immodulon’s lead immunotherapy compound IMM-101”.

  • Immodulon Therapeutics appointments two new board of directors Immodulon Therapeutics appointments two new board of directors

    Immodulon Therapeutics appointments two new board of directors. Anthony Bolton and Sir Simon Robertson join the biopharma firm. ... Immodulon Therapeutics, a privately held, late-stage biopharmaceutical company focused on immuno-oncology has made two new

More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...

Infographics